Mid-term outcome of de novo lesions vs. in stent restenosis treated by intravascular lithotripsy procedures: Insights from the French Shock Initiative.

MLA

Honton, Benjamin, et al. “Mid-Term Outcome of de Novo Lesions vs. in Stent Restenosis Treated by Intravascular Lithotripsy Procedures: Insights from the French Shock Initiative.” International Journal of Cardiology, vol. 365, Oct. 2022, pp. 106–11. EBSCOhost, https://doi.org/10.1016/j.ijcard.2022.07.023.

APA

Honton, B., Lipiecki, J., Monségu, J., Leroy, F., Benamer, H., Commeau, P., Motreff, P., Cayla, G., Banos, J. L., Bouchou, G., Laperche, C., Farah, B., Rangé, G., Lefèvre, T., & Amabile, N. (2022). Mid-term outcome of de novo lesions vs. in stent restenosis treated by intravascular lithotripsy procedures: Insights from the French Shock Initiative. International Journal of Cardiology, 365, 106–111. https://doi.org/10.1016/j.ijcard.2022.07.023

Chicago

Honton, Benjamin, Janusz Lipiecki, Jacques Monségu, Fabrice Leroy, Hakim Benamer, Philippe Commeau, Pascal Motreff, et al. 2022. “Mid-Term Outcome of de Novo Lesions vs. in Stent Restenosis Treated by Intravascular Lithotripsy Procedures: Insights from the French Shock Initiative.” International Journal of Cardiology 365 (October): 106–11. doi:10.1016/j.ijcard.2022.07.023.